Malignant Thyroid Gland Neoplasm — Trials

Malignant Thyroid Gland Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

790 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 176
Recruiting: 92
Ph III recruiting: 12
Growth YoY: +4.9%
Industry share: 13%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 25.9%
Trials / 1,000 deaths: 81.9 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (65)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01496313	To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancer	completed	Phase 4	81	SanofiINDUSTRY	9	Oct 3, 2025	clinicaltrials
NCT06697782	Aprepitant and Ondansetron Monotherapy or Combination for Postoperative Nausea and Vomiting in Thyroid Cancer	completed	Phase 4	600	The First Affiliated Hospital of Zhengzhou UniversityOTHER	1	Jan 22, 2025	clinicaltrials